Viewing Study NCT00144261


Ignite Creation Date: 2025-12-24 @ 12:07 PM
Ignite Modification Date: 2026-01-03 @ 3:10 AM
Study NCT ID: NCT00144261
Status: COMPLETED
Last Update Posted: 2025-01-31
First Post: 2005-09-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Metabolism, Lipids View
Keywords: